» Articles » PMID: 12019204

Increase in Urea in Conjunction with L-arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): the Role of Urea in CYP2E1 Induction by Acute Renal Failure

Overview
Specialty Pharmacology
Date 2002 May 23
PMID 12019204
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A number of xenobiotics and certain pathophysiological situations cause the induction of CYP2E1. The present study was designed to establish the role of plasma urea nitrogen and L-arginine on hepatic CYP2E1 expression in rats or rats with acute renal failure. Exposure of rats to a single intravenous dose of 5 mg/kg uranyl nitrate caused renal failure in 5 days (ARF), as evidenced by increases in plasma urea nitrogen level and kidney to body weight ratio. Northern and Western blot analyses revealed that hepatic CYP2E1 was 2- to 4-fold induced by ARF. Treatment of rats with either 10% glucose in drinking water for 5 days following a single injection of uranyl nitrate or two injections of recombinant growth hormone (5 units/kg, s.c., twice a day) on the 4th day after uranyl nitrate injection reduced both the rise in plasma urea nitrogen and the induction of CYP2E1. Exposure of rats to urea (approximately 225 mg/kg/day) in drinking water for 1 to 3 day(s) resulted in significant increases in CYP2E1 mRNA and protein. Furthermore, perfusion of the liver with 25 mM urea for 24 h resulted in CYP2E1 induction with an increase in the mRNA. The levels of CYP2E1 protein and mRNA were increased in rats perfused with 25 mM L-arginine for 24 h (i.e., a 4-fold increase). Hence, L-arginine, which is irreversibly hydrolyzed to urea and ornithine by arginase, also induced hepatic CYP2E1. The results of the present study provided evidence that increases in plasma urea in conjunction with L-arginine metabolism lead to the induction of CYP2E1 in the liver.

Citing Articles

Consequences of renal failure on non-renal clearance of drugs.

Lalande L, Charpiat B, Leboucher G, Tod M Clin Pharmacokinet. 2014; 53(6):521-32.

PMID: 24861189 DOI: 10.1007/s40262-014-0146-1.


Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism.

Dixon J, Lane K, MacPhee I, Philips B Int J Mol Sci. 2014; 15(2):2538-53.

PMID: 24531139 PMC: 3958866. DOI: 10.3390/ijms15022538.


Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters.

Rendic S, Guengerich F Curr Drug Metab. 2012; 13(6):787-814.

PMID: 22571481 PMC: 4007673. DOI: 10.2174/138920012800840356.


Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

Vilay A, Churchwell M, Mueller B Crit Care. 2008; 12(6):235.

PMID: 19040780 PMC: 2646335. DOI: 10.1186/cc7093.


Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing.

Venkatesh P, Harisudhan T, Choudhury H, Mullangi R, Srinivas N Eur J Drug Metab Pharmacokinet. 2008; 32(4):189-96.

PMID: 18348467 DOI: 10.1007/BF03191003.